“Aspirin Cuts Pancreatic Cancer Risk by Half, Study Finds,” Bloomberg
A recent study from Yale Cancer Center/Smilow Cancer Hospital found that Regular aspirin use cut the risk of pancreatic cancer by half, according to a finding that adds one of the most lethal malignancies to the list of diseases the inexpensive pill may help fight.
Yale Cancer Center/Smilow Cancer Hospital is one of the 25 NCCN Member Institutions.
...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Aspirin | Cancer | Cancer & Oncology | Hospitals | Pancreas | Pancreatic Cancer | Study | Yale